To highlight the barriers in effective obesity care and the need for improved management strategies.
Key Findings:
88% of individuals with obesity experience stigma.
Current care relies heavily on BMI, which may not accurately reflect disease severity.
Only a small proportion of eligible patients receive available obesity treatments.
Stigma influences policy and practice in obesity care.
Obesity should be treated as a chronic disease with individualized management.
Interpretation:
The paper emphasizes the need for health systems to adopt a chronic disease model for obesity, focusing on long-term outcomes and individualized treatment plans.
Limitations:
Causation between the decline in obesity prevalence and increased anti-obesity medication use cannot be established.
Emerging tools like machine learning are not yet integrated into clinical workflows.
Conclusion:
Progress in obesity care requires a shift towards recognizing obesity as a chronic, heterogeneous disease that necessitates long-term, individualized management strategies.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
